| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 02/20/2003 | WO2002068399B1 Aryl carbamate derivatives, preparation and use thereof |
| 02/20/2003 | WO2002064109A3 Mucoadhesive pharmaceutical formulations |
| 02/20/2003 | WO2002049993A3 High affinity small molecule c5a receptor modulators |
| 02/20/2003 | WO2002045738A3 Vaccine composition containing transforming growth factor alpha |
| 02/20/2003 | WO2002030882A9 Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses |
| 02/20/2003 | WO2002030860A9 Ketone compounds and compositions for cholesterol management and related uses |
| 02/20/2003 | WO2002029088A9 Highly expressible genes |
| 02/20/2003 | WO2002024635A3 Aminoalcohol derivatives |
| 02/20/2003 | WO2002022621B1 INTERPHENYLENE 7-OXABICYCLIC[2.2.1]HEPTANE OXAZOLES AS PROSTAGLANDIN F2a ANTAGONISTS |
| 02/20/2003 | WO2002008268A3 Leucine-based motif and clostridial neurotoxins |
| 02/20/2003 | WO2001056547B1 Preparation of aqueous clear solution dosage forms with bile acids |
| 02/20/2003 | US20030036651 As phosphodiesterase inhibitor for prophylaxis and therapy of bronchial asthma; pneumonic diseases, pulmonary emphysema, chronic obstructive pulmonary disease acute respiratory distress syndrome (ARDS), and other respiratory diseases |
| 02/20/2003 | US20030036560 Methods and compositions for treating and preventing mucositis |
| 02/20/2003 | US20030036554 Oxidizing the corresponding sulfide without sulfone production to product purer omerprazole, lansoprazole, pantoprazole, rabeprazole, etc. |
| 02/20/2003 | US20030036552 Novel compounds |
| 02/20/2003 | US20030036549 Methods for treating irritable bowel syndrome |
| 02/20/2003 | US20030036543 Especially as inhibitors of Aurora-2 and GSK-3, for treating diseases such as cancer, diabetes and Alzheimer's disease. |
| 02/20/2003 | US20030036507 Urocortin-III and uses thereof |
| 02/20/2003 | US20030036504 Modululation of both fasting and postprandial lipid levels. |
| 02/20/2003 | US20030036501 Novel peptides as NS3-serine protease inhibitors of hepatitis C virus |
| 02/20/2003 | US20030036500 Methods and compositions using (+) norcisapride in combination with proton pump inhibitors or H2 receptor antagonists |
| 02/20/2003 | US20030036184 Polypeptides exhibiting PDE7 activity and their use for selecting compounds which inhibit PDE 7 enzyme activity |
| 02/20/2003 | US20030036110 Isolation of viral envelope proteins; obtain cells transform with vector containing viral protein, propagate cell, lyse cells, recover envelope proteins |
| 02/20/2003 | US20030036075 Nucleotide sequences coding transport protein for us in the treatment and diagnosis of cancer, arthritis, vision defects and skin dsorders |
| 02/20/2003 | US20030035835 Protective overcoatings |
| 02/20/2003 | CA2456881A1 Somatostatin analogues and their use somatostatin analogues binding to all somatostatin receptor and their use |
| 02/20/2003 | CA2456762A1 Interleukin-1 receptors in the treatment of diseases |
| 02/20/2003 | CA2456599A1 Spiro compounds |
| 02/20/2003 | CA2456533A1 Histone deacetylase enzyme-inhibiting derivatives of hydroxamic acid as new cytokine synthesis-inhibiting anti-inflammatory drugs |
| 02/20/2003 | CA2456328A1 Complexes of a short cpg-containing oligonucleotide bound to the surface of a solid phase microcarrier and methods for use thereof |
| 02/20/2003 | CA2456291A1 Hydroxamic acid derivatives |
| 02/20/2003 | CA2456250A1 Arylsulfonyl derivatives with 5-ht6 receptor affinity |
| 02/20/2003 | CA2456144A1 A group of novel anti-cancer compounds with specific structure |
| 02/20/2003 | CA2456124A1 Substituted 5,6,6a,11b-tetrahydro-7-oxa-5-aza-benzo[c]fluorene-6-carboxylic acid derivatives serving as nmda antagonists |
| 02/20/2003 | CA2456103A1 Salts of substituted 1, 2, 3, 4-tetrahydroquinoline-2-carboxylic acid derivatives |
| 02/20/2003 | CA2455871A1 Substituted pyridin-4-ones and their use as gonadotropin-releasing hormone receptor antagonists. |
| 02/20/2003 | CA2455761A1 Artichoke leaf extracts |
| 02/20/2003 | CA2455391A1 Nutritional supplements and methods of using same |
| 02/20/2003 | CA2454648A1 Irinotecan for treatment of cancer |
| 02/20/2003 | CA2454643A1 Methods for the treatment of cancer with irinotecan based on cyp3a5 |
| 02/20/2003 | CA2454640A1 Methods for treatment of cancer using irinotecan based on ugt1a1 |
| 02/20/2003 | CA2454637A1 Use of irinotecan for improved treatment of cancer based on mdr1 |
| 02/20/2003 | CA2454627A1 Methods for improved treatment of cancer with irinotecan based on mrp1 |
| 02/20/2003 | CA2454417A1 Novel benzo-fused heterocycles as endothelin antagonists |
| 02/20/2003 | CA2454251A1 Isolation and mobilization of stem cells expressing vegfr-1 |
| 02/20/2003 | CA2453995A1 Tacis and br3 polypeptides and uses thereof |
| 02/20/2003 | CA2453433A1 Methods of use for novel sulfur containing organic nitrate compounds |
| 02/20/2003 | CA2452803A1 Tricyclic imidazopyridines |
| 02/20/2003 | CA2451919A1 Nucleic acids, polypeptides, single nucleotide polymorphisms and methods of use thereof |
| 02/20/2003 | CA2451691A1 Use of r-nsaid compounds for anti-hiv treatment |
| 02/19/2003 | WO2002016574A2 Method for identifying peptides that can be specifically cleaved and the use of peptide sequences of this type |
| 02/19/2003 | EP1284265A1 Benzothiophene derivatives and medicinal use thereof |
| 02/19/2003 | EP1284139A1 Novel fatty acid analogues for the treatment of fatty liver |
| 02/19/2003 | EP1283886A2 Intracellular signaling proteins |
| 02/19/2003 | EP1283848A2 Protein complexes and assays for screening anti-cancer agents |
| 02/19/2003 | EP1283835A2 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as protein kinase modulators |
| 02/19/2003 | EP1283827A2 Caspase inhibitors and uses thereof |
| 02/19/2003 | EP1283823A1 Novel mmp-2/mmp-9 inhibitors |
| 02/19/2003 | EP1283723A2 Combination therapy using cox-2 selective inhibitor and thromboxane inhibitor and compositions therefor |
| 02/19/2003 | EP1283721A1 Anti-rank ligand monoclonal antibodies useful in treatment of rank ligand mediated disorders |
| 02/19/2003 | EP1283715A1 Modulaton of alpha-6 integrin-mediated responses |
| 02/19/2003 | EP1283703A1 Rapidly disintegrating tablet and process for the manufacture thereof |
| 02/19/2003 | EP1207878B1 Treatment of migraine by the administration of alpha-lipoic acid or derivatives thereof |
| 02/19/2003 | EP1165559B1 1,4-diazabicyclo[3.2.2]nonane-4-carboxylate and carboxamide derivatives, production and use thereof in therapeutics |
| 02/19/2003 | EP1131327B1 Prostaglandin conjugates for treating or preventing bone diseases |
| 02/19/2003 | EP1119571B1 Tricyclic delta3-piperidines as alpha2-antagonists |
| 02/19/2003 | EP1020466B1 5,11-DIHYDRODIBENZ[b,e][1,4]OXAZEPINE DERIVATIVES AND MEDICINAL COMPOSITION CONTAINING THE SAME |
| 02/19/2003 | EP0959892B1 Use of pvp or povidone for reducing bowel distension |
| 02/19/2003 | EP0920425B1 Substituted 4-(1h-benzimidazol-2-yl-amino)piperidines useful for the treatment of allergic diseases |
| 02/19/2003 | EP0863752B1 Use of allylamine derivatives such as terbinafine, in the manufacture of a medicament for the treatment of helicobacter pylori infection of associated diseases |
| 02/19/2003 | EP0795024B1 Enantioselective preparation of pharmaceutically active sulfoxides by biooxidation |
| 02/19/2003 | CN1398260A 二肽腈组织蛋白酶k抑制剂 Dipeptide nitrile cathepsin inhibitors k |
| 02/19/2003 | CN1398189A Combination therapy of radiation and COX-2 inhibitor for treatment of neoplasia |
| 02/19/2003 | CN1398187A Method and compsns. for treating liver cell cancer |
| 02/19/2003 | CN1397553A Process for preparing Nizatidine |
| 02/19/2003 | CN1397344A Compound steam cell medicine, its preparing process and its application |
| 02/19/2003 | CN1397335A Application of dandelion herb in preparing medicines |
| 02/19/2003 | CN1397334A Medicine for infant to invigorate function of spleen and expel stagnation and its preparing process |
| 02/19/2003 | CN1397331A Healht-care products for vigorating function of spleen and stomach, delaying sanility and promoting intelligence development |
| 02/19/2003 | CN1397319A Health-care medical wine 'Shenfeng Yikang' and its preparing process |
| 02/19/2003 | CN1397317A Prescription and preparing process of 'Changning' gel |
| 02/19/2003 | CN1397315A Medicine for treating diseases of liver, gallbladder and kidney and its preparing process |
| 02/19/2003 | CN1397314A Medicine for treating diseases of liver, gallbladder and kidney and its preparing process |
| 02/19/2003 | CN1397313A Medicine for treating gastroenteropathy and its preparing process |
| 02/19/2003 | CN1397312A Medicine for treating astroenteropathy and its preparing process |
| 02/19/2003 | CN1397288A 'Fuling Yangxin Anzang' pill for nourishing heart and viscera |
| 02/19/2003 | CN1397285A Medicine containing dragonfly and male silkworm moth |
| 02/19/2003 | CN1397283A Chemical treatment compositions |
| 02/19/2003 | CN1397277A Process for preapring silymanium injection |
| 02/19/2003 | CN1101823C Shark liver irritant for preventing and treating hepatism and its prepn. process |
| 02/19/2003 | CN1101696C Enterogastric disease treating medicine and its prepn. method |
| 02/19/2003 | CN1101687C Pill for treating hepatitis B |
| 02/19/2003 | CN1101673C Oral-cavity cleaning liquor for preventing and treating disease of oral cavity and prepn. method |
| 02/19/2003 | CA2420065A1 Methods for indentifying specifically cleavable peptides and use of such peptide sequences |
| 02/18/2003 | WO2002016329A1 Novel phenylalanine derivatives |
| 02/18/2003 | US6521759 Aminothiazole inhibitors of cyclin dependent kinases |
| 02/18/2003 | US6521666 Inhibitors of α4 mediated cell adhesion |
| 02/18/2003 | US6521657 Indole derivatives which are agonists of the progesterone receptor and useful for treatment of carcinoma and adenocarcinomas of uterine leiomyomata, endometriosis or polycystic ovary syndorme in a mammal |
| 02/18/2003 | US6521655 Substituted imidazoles useful in the treatment of inflammatory diseases |
| 02/18/2003 | US6521654 Substituted imidazolidine derivatives, their preparation, their use and pharmaceutical preparations including them |